Genetics of cardiovascular disease: Importance of sex and ethnicity

Atherosclerosis

Volumn 241, Issue 1, 2014, Pages 219-228

  Winham, Stacey J ^a   de Andrade, Mariza ^a   Miller, Virginia M ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Atherosclerosis; Carotid intima medial thickness; Coronary arterial calcification; Men; Sex chromosomes; Women

Indexed keywords

APOLIPOPROTEIN E4; CARBAMOYL PHOSPHATE SYNTHASE; CONJUGATED ESTROGEN; CYCLIN D2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR; GASTRIC INHIBITORY POLYPEPTIDE; GELATINASE B; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; NORADRENALIN; OSTEOCALCIN; OSTEOPONTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEOCHONDROITIN SULFATE; SEX HORMONE; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE; TRIACYLGLYCEROL; TYROSINE 3 MONOOXYGENASE;

ABDOMINAL OBESITY; ALZHEIMER DISEASE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CAG REPEAT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHROMOSOME SEGREGATION; CLINICAL TRIAL (TOPIC); CONFOUNDING VARIABLE; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY DISEASE; DRUG EFFICACY; DYSLIPIDEMIA; ETHNICITY; FATTY ACID OXIDATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEART FAILURE; HEART INFARCTION; HEREDITY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; LIFESTYLE; MALE INFERTILITY; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STATISTICAL ANALYSIS; X CHROMOSOME INACTIVATION; Y CHROMOSOME; AGE; ANCESTRY GROUP; COMORBIDITY; ETHNOLOGY; FEMALE; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; HEALTH DISPARITY; MALE; METABOLISM; PHENOTYPE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SEX FACTOR; X CHROMOSOME;

AGE FACTORS; CARDIOVASCULAR DISEASES; CHROMOSOMES, HUMAN, X; CHROMOSOMES, HUMAN, Y; COMORBIDITY; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GONADAL HORMONES; HEALTH STATUS DISPARITIES; HUMANS; MALE; PHENOTYPE; PROGNOSIS; RACIAL GROUPS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 84945543789     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.03.021     Document Type: Article

References (121)

1. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Blaha M.J., et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014, 129:e28-e292.
2. World Health Organization - The top 10 causes of death, Fact Sheet N310 (2011).
3. Deo R., Albert C.M. Epidemiology and genetics of sudden cardiac death. Circulation 2012, 125:620-637.
4. Li X. Sex chromosomes and sex chromosome abnormalities. Clin. Lab. Med. 2011, 31:463-479. vii.
5. Abramowitz L.K., Olivier-Van Stichelen S., Hanover J.A. Chromosome imbalance as a driver of sex disparity in disease. J. Genomics 2014, 2:77-88.
6. Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D., et al. The DNA sequence of the human X chromosome. Nature 2005, 434:325-337.
7. Lahn B.T., Page D.C. Four evolutionary strata on the human X chromosome. Science 1999, 286:964-967.
8. Bellott D.W., Hughes J.F., Skaletsky H., Brown L.G., Pyntikova T., Cho T.J., et al. Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators. Nature 2014, 508:494-499.
9. Lahn B.T., Page D.C. Functional coherence of the human Y chromosome. Science 1997, 278:675-680.
10. Mueller J.L., Skaletsky H., Brown L.G., Zaghlul S., Rock S., Graves T., et al. Independent specialization of the human and mouse X chromosomes for the male germ line. Nat. Genet. 2013, 45:1083-1087.
11. Skaletsky H., Kuroda-Kawaguchi T., Minx P.J., Cordum H.S., Hillier L., Brown L.G., et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 2003, 423. 825-U822.
12. Sinclair A.H., Berta P., Palmer M.S., Hawkins J.R., Griffiths B.L., Smith M.J., et al. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 1990, 346:240-244.
13. Khil P.P., Smirnova N.A., Romanienko P.J., Camerini-Otero R.D. The mouse X chromosome is enriched for sex-biased genes not subject to selection by meiotic sex chromosome inactivation. Nat. Genet. 2004, 36:642-646.
14. Graves J.A. Review: sex chromosome evolution and the expression of sex-specific genes in the placenta. Placenta 2010, 31(Suppl. l):S27-S32.
15. Disteche C.M. Dosage compensation of the sex chromosomes. Annu. Rev. Genet. 2012, 46:537-560.
16. Deng X.X., Hiatt J.B., Nguyen D.K., Ercan S., Sturgill D., Hillier L.W., et al. Evidence for compensatory upregulation of expressed X-linked genes in mammals, Caenorhabditis elegans and Drosophila melanogaster. Nat. Genet. 2011, 43. 1179-U1128.
17. Brown C.J., Ballabio A., Rupert J.L., Lafreniere R.G., Grompe M., Tonlorenzi R., et al. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature 1991, 349:38-44.
18. Wu H., Luo J., Yu H., Rattner A., Mo A., Wang Y., et al. Cellular resolution maps of X chromosome inactivation: implications for neural development, function, and disease. Neuron 2014, 81:103-119.
19. Chung I.M., Schwartz S.M., Murry C.E. Clonal architecture of normal and atherosclerotic aorta: implications for atherogenesis and vascular development. Am. J. Pathol. 1998, 152:913-923.
20. Berletch J.B., Yang F., Xu J., Carrel L., Disteche C.M. Genes that escape from X inactivation. Hum. Genet. 2011, 130:237-245.
21. Carrel L., Willard H.F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005, 434:400-404.
22. Wise A.L., Gyi L., Manolio T.A. eXclusion: toward integrating the X chromosome in genome-wide association analyses. Am. J. Hum. Genet. 2013, 92:643-647.
23. Wang Q.J., Lu C.Y., Li N., Rao S.Q., Shi Y.B., Han D.Y., et al. Y-linked inheritance of non-syndromic hearing impairment in a large Chinese family. J. Med. Genet. 2004, 41:e80.
24. Wang Q., Xue Y., Zhang Y., Long Q., Asan, Yang F., et al. Genetic basis of Y-linked hearing impairment. Am. J. Hum. Genet. 2013, 92:301-306.
25. Hindorff L.A., Sethupathy P., Junkins H.A., Ramos E.M., Mehta J.P., Collins F.S., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9362-9367.
26. Kent W.J., Sugnet C.W., Furey T.S., Roskin K.M., Pringle T.H., Zahler A.M., et al. The human genome browser at UCSC. Genome Res. 2002, 12:996-1006.
27. Yue F., Cheng Y., Breschi A., Vierstra J., Wu W., Ryba T., et al. A comparative encyclopedia of DNA elements in the mouse genome. Nature 2014, 515:355-364.
28. Yang P.C., Clancy C.E. Effects of sex hormones on cardiac repolarization. J. Cardiovasc. Pharmacol. 2010, 56:123-129.
29. Olivotto I., Maron M.S., Adabag A.S., Casey S.A., Vargiu D., Link M.S., et al. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 2005, 46:480-487.
30. Meyer S., van der Meer P., van Tintelen J.P., van den Berg M.P. Sex differences in cardiomyopathies. Eur. J. Heart Fail 2014, 16:238-247.
31. Towne B., Siervogel R.M., Blangero J. Effects of genotype-by-sex interaction on quantitative trait linkage analysis. Genet. Epidemiol. 1997, 14:1053-1058.
32. Williams S.R., Yang Q., Chen F., Liu X., Keene K.L., Jacques P., et al. Genome-wide meta-analysis of homocysteine and methionine metabolism identifies five one carbon metabolism loci and a novel association of ALDH1L1 with ischemic stroke. PLoS Genet. 2014, 10:e1004214.
33. Wang D., Yang H., Quinones M.J., Bulnes-Enriquez I., Jimenez X., De La Rosa R., et al. A genome-wide scan for carotid artery intima-media thickness: the Mexican-American Coronary Artery Disease family study. Stroke 2005, 36:540-545.
34. O'Donnell C.J., Cupples L.A., D'Agostino R.B., Fox C.S., Hoffmann U., Hwang S.J., et al. Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study. BMC Med. Genet. 2007, 8(Suppl. 1):S4.
35. Lange L.A., Lange E.M., Bielak L.F., Langefeld C.D., Kardia S.L., Royston P., et al. Autosomal genome-wide scan for coronary artery calcification loci in sibships at high risk for hypertension. Arterioscler. Thromb. Vac. Biol. 2002, 22:418-423.
36. Stamova B., Tian Y., Jickling G., Bushnell C., Zhan X., Liu D., et al. The X-chromosome has a different pattern of gene expression in women compared with men with ischemic stroke. Stroke; a J. Cereb. Circ. 2012, 43:326-334.
37. Chen Y.C., Guo X., Raffel L.J., Xiang A.H., Fang B., Hsueh W.A., et al. Carotid intima-media thickness (cIMT) cosegregates with blood pressure and renal function in hypertensive Hispanic families. Atherosclerosis 2008, 198:160-165.
38. Jiang Y., Kohara K., Hiwada K. Association between risk factors for atherosclerosis and mechanical forces in carotid artery. Stroke 2000, 31:2319-2324.
39. Xiang A.H., Azen S.P., Buchanan T.A., Raffel L.J., Tan S., Cheng L.S., et al. Heritability of subclinical atherosclerosis in Latino families ascertained through a hypertensive parent. Arterioscler. Thromb. Vac. Biol. 2002, 22:843-848.
40. Fox C.S., Polak J.F., Chazaro I., Cupples A., Wolf P.A., D'Agostino R.A., et al. Genetic and environmental contributions to atherosclerosis phenotypes in men and women: heritability of carotid intima-media thickness in the Framingham Heart Study. Stroke 2003, 34:397-401.
41. Turner M.E., Farkas J., Dunmire J., Ely D., Milsted A. Which sry locus is the hypertensive Y chromosome locus?. Hypertension 2009, 53:430-435.
42. Ehret G.B., Munroe P.B., Rice K.M., Bochud M., Johnson A.D., Chasman D.I., et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011, 478:103-109.
43. Charchar F.J., Tomaszewski M., Strahorn P., Champagne B., Dominiczak A.F. Y is there a risk to being male?. Trends Endocrinol. Metab. 2003, 14:163-168.
44. Humma L.M., Puckett B.J., Richardson H.E., Terra S.G., Andrisin T.E., Lejeune B.L., et al. Effects of beta1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia. Am. J. Cardiol. 2001, 88:1034-1037.
45. Pacanowski M.A., Zineh I., Li H., Johnson B.D., Cooper-DeHoff R.M., Bittner V., et al. Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation. J. Transl. Med. 2008, 6:11.
46. Pacanowski M.A., Gong Y., Cooper-Dehoff R.M., Schork N.J., Shriver M.D., Langaee T.Y., et al. Beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension. Clin. Pharmacol. Ther. 2008, 84:715-721.
47. Rahimi Z., Aghaei A., Vaisi-Raygani A. AT2R -1332 G: A polymorphism and its interaction with AT1R 1166 A: C, ACE I/D and MMP-9 -1562 C: T polymorphisms: risk factors for susceptibility to preeclampsia. Gene 2014, 538:176-181.
48. Bairey Merz C.N., Mark S., Boyan B.D., Jacobs A.K., Shah P.K., Shaw L.J., et al. Proceedings from the scientific symposium: sex differences in cardiovascular disease and implications for therapies. J. Womens Health (Larchmt) 2010, 19:1059-1072.
49. Mosca L., Benjamin E.J., Berra K., Bezanson J.L., Dolor R.J., Lloyd-Jones D.M., et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the american heart association. Circulation 2011, 123:1243-1262.
50. Bloomer L.D., Nelson C.P., Eales J., Denniff M., Christofidou P., Debiec R., et al. Male-specific region of the Y chromosome and cardiovascular risk: phylogenetic analysis and gene expression studies. Arterioscler. Thromb. Vac. Biol. 2013, 33:1722-1727.
51. Charchar F.J., Bloomer L.D.S., Barnes T.A., Cowley M.J., Nelson C.P., Wang Y., et al. New insights into inheritance of coronary artery disease in men - the role of the Y sex chromosome. Lancet 2012, 379:915-922.
52. Libby P., Ridker P.M., Hansson G.K. Inflammation in atherosclerosis: from pathophysiology to practice. J. Am. Coll. Cardiol. 2009, 54:2129-2138.
53. Sowers M.R., Symons J.P., Jannausch M.L., Chu J., Kardia S.R. Sex steroid hormone polymorphisms, high-density lipoprotein cholesterol, and apolipoprotein A-1 from the Study of Women's Health across the Nation (SWAN). Am. J. Med. 2006, 119:S61-S68.
54. Olson M.B., Kelsey S.F., Matthews K., Shaw L.J., Bharaf B.L., Pohost G.M., et al. Symptoms, myocardial ischaemia and quality of life in women: results from the NHLBI-sponsored WISE Study. Eur. Heart J. 2003, 24:1506-1514.
55. Willer C.J., Sanna S., Jackson A.U., Scuteri A., Bonnycastle L.L., Clarke R., et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 2008, 40:161-169.
56. Carlquist J.F., McKinney J.T., Horne B.D., Camp N.J., Cannon-Albright L., Muhlestein J.B., et al. Common variants in 6 lipid-related genes discovered by high-resolution DNA melting analysis and their association with plasma lipids. J. Clin. Exp. Cardiol. 2011, 2.
57. Aulchenko Y.S., Ripatti S., Lindqvist I., Boomsma D., Heid I.M., Pramstaller P.P., et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat. Genet. 2009, 41:47-55.
58. Asselbergs F.W., Guo Y., van Iperen E.P., Sivapalaratnam S., Tragante V., Lanktree M.B., et al. Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am. J. Hum. Genet. 2012, 91:823-838.
59. Teslovich T.M., Musunuru K., Smith A.V., Edmondson A.C., Stylianou I.M., Koseki M., et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466:707-713.
60. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials. Lancet 2015, 10.1016/S0140-6736(14)61368-4.
61. Swerdlow D.I., Preiss D., Kuchenbaecker K.B., Holmes M.V., Engmann J.E., Shah T., et al. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet 2014, 385:351-361.
62. Goodarzi M.O., Li X., Krauss R.M., Otter J.I., Chien Y.I. Relationship of sex to diabetes risk in statin trials. Diabetes Care 2013, 36:e100-e101.
63. Stone N.J., Robinson J.G., Lichtenstein A.H., Goff D.C., Lloyd-Jones D.M., Smith S.C., et al. Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline. Ann. Intern. Med. 2014, 160:339-343.
64. Mosca L. Sex, statins, and statistics. Lancet 2015 Jan 13, pii: S0140-6736(14)62005-5. [Epub ahead of print]. 10.1016/S0140-6736(14)62005-5.
65. Alexander C.M., Landsman P.B., Teutsch S.M., Haffner S.M. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003, 52:1210-1214.
66. Jayachandran M., Litwiller R.D., Lahr B.D., Bailey K.R., Owen W.G., Mulvagh S.L., et al. Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk. J. Cardiovasc. Transl. Res. 2011, 4:811-822.
67. Regitz-Zagrosek V., Lehmkuhl E., Weickert M.O. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin. Res. Cardiol. 2006, 95:136-147.
68. Heid I.M., Jackson A.U., Randall J.C., Winkler T.W., Qi L., Steinthorsdottir V., et al. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat. Genet. 2010, 42:949-960.
69. Li H.Y., Wu R.L., Lin M., Terra S.G., Pepine C.J., McGorray S.P., et al. Epistatic control of human obesity as revealed by linkage disequilibrium mapping: a report from the NHLBI-sponsored WISE study. Curr. Genomics 2006, 7:463-468.
70. Randall J.C., Winkler T.W., Kutalik Z., Berndt S.I., Jackson A.U., Monda K.L., et al. Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet. 2013, 9:e1003500.
71. Ohlstein J.F., Strong A.L., McLachlan J.A., Gimble J.M., Burow M.E., Bunnell B.A. Bisphenol A enhances adipogenic differentiation of human adipose stromal/stem cells. J. Mol. Endocrinol. 2014, 53:345-353.
72. Ma H., Sprecher H.W., Kolattukudy P.E. Estrogen-induced production of a peroxisome proliferator-activated receptor (PPAR) ligand in a PPARgamma-expressing tissue. J. Biol. Chem. 1998, 273:30131-30138.
73. Lehrke M., Lazar M.A. The many faces of PPARgamma. Cell 2005, 123:993-999.
74. Yano M., Matsumura T., Senokuchi T., Ishii N., Murata Y., Taketa K., et al. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages. Circ. Res. 2007, 100:1442-1451.
75. Morris A.P., Voight B.F., Teslovich T.M., Ferreira T., Segre A.V., Steinthorsdottir V., et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 2012, 44:981-990.
76. Mittelstrass K., Ried J.S., Yu Z., Krumsiek J., Gieger C., Prehn C., et al. Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet. 2011, 7:e1002215.
77. Chang A.Y., Wild R.A. Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts?. Semin. Reprod. Med. 2009, 27:299-305.
78. Juo S.H. Genetics of carotid atherosclerosis. Front. Biosci. 2009, 14:4525-4534.
79. Wang L., Beecham A., Zhuo D., Dong C., Blanton S.H., Rundek T., et al. Fine mapping study reveals novel candidate genes for carotid intima-media thickness in dominican republican families. Circ. Cardiovasc. Genet. 2012, 5:234-241.
80. Miller V.M., Petterson T.M., Jeavons E.N., Lnu A.S., Rider D.N., Heit J.A., et al. Genetic polymorphisms associated carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study. Physiol. Genomics 2013, 45:79-88.
81. Mitchell G.F., Guo C.Y., Kathiresan S., Vasan R.S., Larson M.G., Vita J.A., et al. Vascular stiffness and genetic variation at the endothelial nitric oxide synthase locus: the Framingham Heart study. Hypertension 2007, 49:1285-1290.
82. Payami H., Zareparsi S., Montee K.R., Sexton G.J., Kaye J.A., Bird T.D., et al. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am. J. Hum. Genet. 1996, 58:803-811.
83. Chambless L.E., Folsom A.R., Clegg L.X., Sharrett A.R., Shahar E., Nieto F.J., et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am. J. Epidemiol. 2000, 151:478-487.
84. Liao Y.C., Lin H.F., Guo Y.C., Yu M.L., Liu C.K., Juo S.H. Sex-differential genetic effect of phosphodiesterase 4D (PDE4D) on carotid atherosclerosis. BMC Med. Genet. 2010, 11:93.
85. Ridker P.M., Cook N.R., Lee I.M., Gordon D., Gaziano J.M., Manson J.E., et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N. Engl. J. Med. 2005, 352:1293-1304.
86. Bild D.E., Detrano R., Peterson D., Guerci A., Liu K., Shahar E., et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2005, 111:1313-1320.
87. Abilleira S., Bevan S., Markus H.S. The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis. J. Med. Genet. 2006, 43:897-901.
88. Taylor B.C., Schreiner P.J., Doherty T.M., Fornage M., Carr J.J., Sidney S. Matrix Gla protein and osteopontin genetic associations with coronary artery calcification and bone density: the CARDIA study. Hum. Genet. 2005, 116:525-528.
89. Burdon K.P., Langefeld C.D., Beck S.R., Wagenknecht L.E., Carr J.J., Rich S.S., et al. Variants of the CD40 gene but not of the CD40L gene are associated with coronary artery calcification in the Diabetes Heart Study (DHS). Am. Heart J. 2006, 151:706-711.
90. Wojczynski M.K., Li M., Bielak L.F., Kerr K.F., Reiner A.P., Wong N.D., et al. Genetics of coronary artery calcification among African Americans, a meta-analysis. BMC Med. Genet. 2013, 14:75.
91. Miller V.M., Black D.M., Brinton E.A., Budoff M.J., Cedars M.I., Hodis H.N., et al. Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J. Cardiovasc. Transl. Res. 2009, 2:228-239.
92. Manson J., Allison M., Rossouw J.E., Carr J., Langer R., Hsia J., et al. Estrogen therapy and coronary-artery calcification. N. Engl. J. Med. 2007, 356:2591-2602.
93. Liao Y.C., Lin H.F., Rundek T., Cheng R., Guo Y.C., Sacco R.L., et al. Segment-specific genetic effects on carotid intima-media thickness: the Northern Manhattan study. Stroke 2008, 39:3159-3165.
94. Goodarzi M.O., Taylor K.D., Guo X., Quinones M.J., Cui J., Li Y., et al. Association of the diabetes gene calpain-10 with subclinical atherosclerosis: the Mexican-American Coronary Artery Disease Study. Diabetes 2005, 54:1228-1232.
95. Guthery S.L., Salisbury B.A., Pungliya M.S., Stephens J.C., Bamshad M. The structure of common genetic variation in United States populations. Am. J. Hum. Genet. 2007, 81:1221-1231.
96. Lu X., Wang L., Chen S., He L., Yang X., Shi Y., et al. Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat. Genet. 2012, 44:890-894.
97. Sudhir K., Chou T.M., Chatterjee K., Smith E.P., Williams T.C., Kane J.P., et al. Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation 1997, 96:3774-3777.
98. Sudhir K., Chou T.M., Messina L.M., Hutchison S.J., Korach K.S., Chatterjee K., et al. Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene. Lancet 1997, 349:1146-1147.
99. Herrington D.M., Howard T.D., Hawkins G.A., Reboussin D.M., Xu J., Zheng S.L., et al. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. New. Engl. J. Med. 2002, 346:967-974.
100. Herrington D.M., Howard T.D., Brosnihan K.B., McDonnell D.P., Li X., Hawkins G.A., et al. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 2002, 105:1879-1882.
101. Rossouw J., Bray P., Liu J., Kooperberg C., Hsia J., Lewis C., et al. Estrogen receptor polymorphisms and the vascular effects of hormone therapy. Arterioscler. Thromb. Vac. Biol. 2011, 31:464-469.
102. Ackerman C.M., Lowe L.P., Lee H., Hayes M.G., Dyer A.R., Metzger B.E., et al. Ethnic variation in allele distribution of the androgen receptor (AR) (CAG)n repeat. J. Androl. 2012, 33:210-215.
103. Page S.T., Kupelian V., Bremner W.J., McKinlay J.B. The androgen receptor gene CAG repeat polymorphism does not predict increased risk of heart disease: longitudinal results from the Massachusetts Male Ageing Study. Clin. Endocrinol. (Oxf.) 2006, 65:333-339.
104. Pausova Z., Abrahamowicz M., Mahboubi A., Syme C., Leonard G.T., Perron M., et al. Functional variation in the androgen-receptor gene is associated with visceral adiposity and blood pressure in male adolescents. Hypertension 2010, 55:706-714.
105. Zitzmann M., Nieschlag E. The CAG repeat polymorphism within the androgen receptor gene and maleness. Int. J. Androl. 2003, 26:76-83.
106. Kim J.J., Choung S.H., Choi Y.M., Yoon S.H., Kim S.H., Moon S.Y. Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome. Fertil. Steril. 2008, 90:2318-2323.
107. Shah N.A., Antoine H.J., Pall M., Taylor K.D., Azziz R., Goodarzi M.O. Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2008, 93:1939-1945.
108. Hebbring S.J., Adjei A.A., Baer J.L., Jenkins G.D., Zhang J., Cunningham J.M., et al. Human SULT1A1 gene: copy number differences and functional implications. Hum. Mol. Genet. 2007, 16:463-470.
109. Raftogianis R.B., Wood T.C., Weinshilboum R.M. Human phenol sulfotransferases SULT1A2 and SULT1A1: genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations. Biochem. Pharmacol. 1999, 58:605-616.
110. Ning B., Nowell S., Sweeney C., Ambrosone C.B., Williams S., Miao X., et al. Common genetic polymorphisms in the 5'-flanking region of the SULT1A1 gene: haplotypes and their association with platelet enzymatic activity. Pharmacogenet Genomics 2005, 15:465-473.
111. Sowers M.R., Wilson A.L., Karvonen-Gutierrez C.A., Kardia S.R. Sex steroid hormone pathway genes and health-related measures in women of 4 races/ethnicities: the Study of Women's Health across the Nation (SWAN). Am. J. Med. 2006, 119:S103-S110.
112. Crandall C.J., Crawford S.L., Gold E.B. Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors. Am. J. Med. 2006, 119:S52-S60.
113. Woods N.F., Mitchell E.S., Tao Y., Viernes H.M., Stapleton P.L., Farin F.M. Polymorphisms in the estrogen synthesis and metabolism pathways and symptoms during the menopausal transition: observations from the Seattle Midlife Women's Health Study. Menopause 2006, 13:902-910.
114. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81:559-575.
115. Clayton D. Testing for association on the X chromosome. Biostatistics 2008, 9:593-600.
116. Howie B., Fuchsberger C., Stephens M., Marchini J., Abecasis G.R. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 2012, 44:955-959.
117. Bloomer L.D., Nelson C.P., Denniff M., Christofidou P., Debiec R., Thompson J., et al. Coronary artery disease predisposing haplogroup I of the Y chromosome, aggression and sex steroids-genetic association analysis. Atherosclerosis 2014, 233:160-164.
118. Dimas A.S., Nica A.C., Montgomery S.B., Stranger B.E., Raj T., Buil A., et al. Sex-biased genetic effects on gene regulation in humans. Genome Res. 2012, 22:2368-2375.
119. Winham S.J., Biernacka J.M. Gene-environment interactions in genome-wide association studies: current approaches and new directions. J. Child Psychol. Psychiatry 2013, 54:1120-1134.
120. Thomas D. Gene-environment-wide association studies: emerging approaches. Nat. Rev. Genet. 2010, 11:259-272.
121. Pritchard J.K., Stephens M., Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000, 155:945-959.